Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Self-reported measures of antiretroviral adherence vary greatly in recall time periods and response tasks. To determine which time frame is most accurate, we compared 3-, 7-day, and 1-month self-reports with data from medication event monitoring system (MEMS). To determine which response task is most accurate we compared three different 1-month self-report tasks (frequency, percent, and rating) to MEMS. We analyzed 643 study visits made by 156 participants. Over-reporting (self-report minus MEMS) was significantly less for the 1-month recall period (9%) than for the 3 (17%) or 7-day (14%) periods. Over-reporting was significantly less for the 1-month rating task (3%) than for the 1-month frequency and percent tasks (both 12%). We conclude that 1-month recall periods may be more accurate than 3- or 7-day periods, and that items that ask respondents to rate their adherence may be more accurate than those that ask about frequencies or percents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a 5-item scale that has been shown sensitive to variations in health states related to HIV, mental health,53,54 and tobacco use.55,56”
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 2×
“We use the Medical Outcome Study 12-item short-form health survey to assess physical and mental health (Ware et al. 1996), and the PC-SAD to assess depression (Rogers et al. 2002).”
MethodPalella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405 · cited 1×
“Highly active antiretroviral therapy (HAART) has led to a dramatic decline in human immunodeficiency virus (HIV) mortality and morbidity (Hogg et al. 1998; Palella et al. 1998).”
BackgroundAdherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289 · cited 1×
“Both clinical trials and cohort studies have shown that adherence to antiretroviral (ARV) medication is one of the most important factors for the success of HAART (Arnsten et al. 2001; Bangsberg et al. 2001; Chesney et al.1999; Paterson et al. 2000).”
BackgroundPreston, C. C., & Colman, A. M. (2000) · Acta Psychologica · doi:10.1016/s0001-6918(99)00050-5 · Cited by 2,106 · cited 2×
“For analysis we assigned the six categories scores of 0, 20, 40, 60, 80, and 100, with 100 being the best adherence ( Preston and Colman 2000 ).”
MethodChesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE (2000) · AIDS Care · doi:10.1080/09540120050042891 · Cited by 1,428 · cited 1×
“The widely used Aids Clinical Trials Group (ACTG) adherence instruments employs a 4-day recall period (Chesney et al. 2000).”
MethodPeters, E., Västfjäll, D., Slovic, P., Mertz, C. K., Mazzocco, K., & Dickert, S. (2006) · Psychological Science · doi:10.1111/j.1467-9280.2006.01720.x · Cited by 1,180
The Role of Numeracy in Understanding the Benefit of Screening Mammography
Schwartz, L. M., Woloshin, S., Black, W. C., & Welch, H. G. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00003 · Cited by 1,130 · cited 1×
“Recognition of health numeracy as an issue for patient self-management and participatory decision-making is growing (Apter et al. 2006; Gazmararian et al. 1999; Montori and Rothman 2005; Peters et al. 2006; Schwartz et al. 1997; Woloshin et al. 2005).”
BackgroundBangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033 · cited 1×
“Poor adherence is associated with treatment failure, resistance, and the transmission of resistant viruses (Bangsberg et al. 2000; Vanhove et al.1996).”
Background
Research works printed but not linked: 2
- Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Suppl A), S271–S278.
- Montori, V. M., Leung, T. W., Thompson, C. A., Chung, J. A., Capes, S. E., & Smith, S. A. (2004). Choice of risk representation to enable diabetes decision-making. Diabetes, 53(Suppl 2), A225.
Cited by
Items 101–200 of 360
Wu, J. R., Lennie, T. A., Jong, M. J. D., Frazier, S. K., Heo, S., Chung, M. L., & Moser, D. K. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.10.017 · Cited by 48
“MEMS was used for 3 months to measure patient’s medication adherence because 3 months has been shown to accurately reflect long-term adherence,(42,43) it avoids overburdening the patient with a longer data collection period, and is longer than many studies in which MEMS was used for less than a month.(32,40,44) Outcom…”
Sidorkiewicz, S., Tran, V.-T., Cousyn, C., Perrodeau, É., & Ravaud, P. (2016) · The Annals of Family Medicine · doi:10.1370/afm.1965 · Cited by 45
Global Action to reduce HIV stigma and discrimination
Stangl, A. L., Grossman, C. I., Sidibé, M., Goosby, E., Grossman, C. I., Stangl, A. L., Katz, I. T., Ryu, A. E., Onuegbu, A., Psaros, C., et al. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.3.18934 · Cited by 56
Cook, P. F., Bremer, R. W., Ayala, A. J., & Kahook, M. Y. (2010) · Clinical ophthalmology · doi:10.2147/opth.s12765 · Cited by 43
Saberi, P., & Johnson, M. O. (2015) · Journal of Health Communication · doi:10.1080/10810730.2015.1018617 · Cited by 38
“Participants’ ability to adhere to ARVs over the past 30 days was assessed using a validated adherence rating scale (Lu et al., 2008) and categorized as excellent versus less than excellent.”
BackgroundMethodInfluentialLiu, A., Hessol, N. A., Vittinghoff, E., Amico, K. R., Kroboth, E., Fuchs, J. D., Irvin, R., Sineath, R. C., Sanchez, T., Sullivan, P. S., et al. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0195 · Cited by 39
“For our primary analysis, we adapted the single-item adherence rating scale, which has been demonstrated to have significantly less over-reporting 20 and has been used as a self-reported adherence measure across several PrEP trials.”
Adherence to levothyroxine among patients with hypothyroidism in Lebanon
Helou, S. E., Hallit, S. R., Awada, S., Al‐Hajje, A., Rachidi, S., Bawab, W., Salameh, P., & Zein, S. (2018) · Eastern Mediterranean Health Journal · doi:10.26719/emhj.18.022 · Cited by 45
Methodological Lessons from Clinical Trials and the Future of Microbicide Research
van der Straten, A., Montgomery, E., Hartmann, M., & Minnis, A. M. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0141-9 · Cited by 38
“in te rv ie w (F T F I) [4 7, 49 ] S el fre po rt ed pr od uc t us e S in gl e tim e po in ts or co nt in uo us N o • • • • A ll S el fre po rt ed se xu al an d”
BackgroundUnannounced Telephone-Based Pill Counts: A Valid and Feasible Method for Monitoring Adherence
Fredericksen, R. J., Feldman, B. J., Brown, T., Schmidt, S. M., Crane, P. K., Harrington, R. D., Dhanireddy, S., McReynolds, J., Lober, W. B., Bangsberg, D. R., et al. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0916-7 · Cited by 36
“The assessment included the following adherence measures: 4-item Adult AIDS Clinical Trial Group (AACTG) instrument [34], a rating scale item [35], and a visual analogue scale item [25, 36, 37].”
Phillips, J. C., Webel, A. R., Rose, C. D., Corless, I. B., Sullivan, K. M., Voss, J. G., Wantland, D. J., Nokes, K. M., Brion, J. M., Chen, W., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-736 · Cited by 40
“We also used a 30-day adherence rating scale that has been recommended by Lu and colleagues [73], in which participants are asked “Thinking back over the past 30 days, rate your ability to take all your medications as prescribed” (6 response ratings: Very poor, Poor, Fair, Good, Very good, and Excellent).”
BackgroundMethodResultThe impact of incident depression on medication adherence in patients with type 2 diabetes
Lunghi, C., Zongo, A., Moisan, J., Grégoire, J., & Guénette, L. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.07.003 · Cited by 37
“Self-administered adherence questionnaires may underestimate nonadherence [23] and may possibly underestimate the association, especially when the recall period is that short [24].”
BackgroundChristopoulos, K., Neilands, T. B., Dilworth, S. E., Lisha, N. E., Sauceda, J. A., Mugavero, M. J., Crane, H. M., Fredericksen, R. J., Mathews, W. C., Moore, R. D., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002595 · Cited by 35
“Copyright © 2020 Wolters Kluwe represents their adherence over the past month, and a single-item self-report measure that uses a five point Likert scale ranging from ‘very poor’ to ‘excellent’ to describe ARTadherence over the past 4 weeks [16].”
Crockett, K. B., Turan, B., Whitfield, S., Kay, E. S., Henna Budhwani, P., Fifolt, M. M., Hauenstein, K., Ladner, M. D., Sewell, J., Payne‐Foster, P., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03470-y · Cited by 50
“Because measures of ART adherence (missed dose counts) tend to have a positive skew, responses were dichotomized as 0 = ≥ 95% adherence (less than or equal to 2 missed doses in the past month), and 1≤95% adherence (more than 2 missed doses in the past month [28, 29].”
BackgroundSauceda, J. A., Wiebe, J. S., & Simoni, J. M. (2014) · Journal of Health Psychology · doi:10.1177/1359105314546341 · Cited by 36
“Past 30-day adherence to ART through the visual analog scale (VAS) has shown to be one of the most accurate time frames and measures for self-reported adherence (Amico et al., 2006; Giordano et al., 2004; Lu et al., 2007; Oyugi et al., 2004).”
BackgroundRampamba, E. M., Meyer, J. C., Godman, B., Kurdi, A. B., & Helberg, E. A. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0004 · Cited by 40
Celano, C. M., Freedman, M. E., Harnedy, L. E., Park, E. R., Januzzi, J. L., Healy, B. C., & Huffman, J. C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110285 · Cited by 39
“: Medication adherence was assessed using the Self-Report Medication Adherence (SRMA) measure, which has been utilized in other psychological intervention studies in medical illness [26,46].”
MethodCrane, H. M., Crane, P. K., Tufano, J. T., Ralston, J. D., Wilson, I. B., Brown, T. D., Davis, T. E., Smith, L. F., Lober, W. B., McReynolds, J., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1718-5 · Cited by 35
Self-citationSaberi, P., Dawson Rose, C., Wootton, A. R., Ming, K., Legnitto, D., Jeske, M., Pollack, L. M., Johnson, M. O., Gruber, V. A., & Neilands, T. B. (2020) · AIDS Care · doi:10.1080/09540121.2019.1622637 · Cited by 32
“back over the past 30 days, rate your ability to take all your medications as prescribed: excellent, very good, good, fair, poor, or very poor”) (Lu et al., 2008).”
BackgroundMagidson, J. F., Li, X., Mimiaga, M. J., Moore, A. T., Srithanaviboonchai, K., Friedman, R. K., Limbada, M., Hughes, J. P., Cummings, V., Gaydos, C. A., et al. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1142-7 · Cited by 32
“Here we used a measure with forced categories of responses, which provide a crude assessment of actual rates of adherence; though this question has shown particular validity compared to a ‘‘percent’’ question [13].”
MethodSelf-citationLaws, M. B., Bradshaw, Y. S., Safren, S. A., Beach, M. C., Lee, Y., Rogers, W. H., & Wilson, I. B. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9844-3 · Cited by 32
Self-citationLaws, M. B., Epstein, L. H., Lee, Y., Rogers, W. H., Beach, M. C., & Wilson, I. B. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.04.013 · Cited by 35
“The clinical trial for which these audio recordings were made is described elsewhere [13–15].”
Self-citationChaiyachati, K. H., Hirschhorn, L. R., Tanser, F. C., Newell, M., & Bärnighausen, T. (2011) · AIDS Patient Care and STDs · doi:10.1089/apc.2010.0257 · Cited by 39
“It 55–57 It will further be important to reassess our knowledge on ART adherence in SSA.”
Holstad, M. M., Foster, V., DiIorio, C. K., McCarty, F., & Teplinskiy, I. (2009) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2009.08.002 · Cited by 30
“…the optimal period has not yet been determined, 30 days seems to correlate better with the clinical indicator of viral load (Simoni et al., 2006) and with electronic drug monitoring (Lu et al., 2008; Walsh, Mandalia, & Gazzard, 2002) when participants typically have monthly cap data downloads.”
BackgroundLee, J., Lee, E., Chae, D., & Kim, C. (2019) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2019.103498 · Cited by 32
Zhang, Q., Li, X., Qiao, S., Shen, Z., & Zhou, Y. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00265-4 · Cited by 32
Da, W., Li, X., Qiao, S., Zhou, Y., & Shen, Z. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203032 · Cited by 32
Johnson, M. O., Neilands, T. B., Koester, K. A., Wood, T., Sauceda, J. A., Dilworth, S. E., Mugavero, M. J., Crane, H. M., Fredericksen, R. J., Mayer, K. H., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002000 · Cited by 30
Wu, Y. P., Aylward, B. S., & Steele, R. G. (2010) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsq014 · Cited by 28
“Recent studies including patients with individuals taking HIV medication provide preliminary evidence that the MEMS method of assessing adherence is valid and reliable (Lu et al., 2008; Müller, Bode, Myer, Roux, & von Steinbüchel, 2008).”
BackgroundGaist, P., & Stirratt, M. J. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001399 · Cited by 30
van den Berg, J. J., Neilands, T. B., Johnson, M. O., Chen, B., & Saberi, P. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0159 · Cited by 29
“In comparison to the 30-day visual analog scale or the detailed 3-day adherence measure developed by the AIDS Clinical Trials Group that asks about frequencies or percentages, this single item has been noted as providing more accurate ART adherence estimates, similar to those provided by medication event monitoring sy…”
Vagiri, R. V., Johanna, C. M., Brian, G., & Andries (2018) · Journal of AIDS and HIV Research · doi:10.5897/jahr2018.0478 · Cited by 30
“Numeric values were assigned to patient-reported adherence ratings based on previous studies conducted at the study sites and published studies on adherence (Mapetla, 2007; Lu et al., 2008; Engelbrecht, 2010; Buscher et al., 2011; Vagiri et al., 2014).”
MethodResultSaberi, P., Chakravarty, D., Ming, K., Legnitto, D., Gandhi, M., Johnson, M. O., & Neilands, T. B. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02744-w · Cited by 28
Blashill, A. J., Mayer, K. H., Crane, H. M., Magidson, J. F., Grasso, C., Mathews, W. C., Saag, M. S., & Safren, S. A. (2013) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9489-3 · Cited by 35
“Studies have advocated for the use of this item, (37) and within the cohort, the validity of its use within routine clinical care for patients with HIV has recently been examined (38).”
MethodSelf-citationBankoff, S. M., McCullough, M. B., & Pantalone, D. W. (2013) · Journal of Health Psychology · doi:10.1177/1359105313475896 · Cited by 27
“…that use of a dichotomous item is the best way to avoid overestimating adherence (Pearson et al., 2007) and that the most valid recall period is 30 days prior to interview (Lu et al., 2008), we report the proportion of our sample indicating 100 percent medication adherence in this time frame.”
BackgroundLaws, M. B., Lee, Y., Rogers, W., Beach, M., Saha, S., Korthuis, P., Sharp, V., Cohn, J. A., Moore, R., & Wilson, I. B. (2014) · Aids and Behavior · doi:10.1007/s10461-014-0697-z · Cited by 24
“100 %) [33].”
Self-citationAnderson, K., Biello, K. B., Rosenberger, J. G., Novak, D. S., Mayer, K. H., Carey, K. B., & Mimiaga, M. J. (2018) · AIDS Care · doi:10.1080/09540121.2018.1456641 · Cited by 25
“for the effect of overestimated self-reports in adherence levels (Lu et al., 2008).”
BackgroundYiğit, İ., Wilson, T. E., Taylor, T., Kassaye, S., Weiser, S. D., Cohen, M. H., Gange, S. J., Pence, B. W., Ofotokun, I., Wingood, G. M., et al. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.117699 · Cited by 32
Lessons learned from an HIV adherence pilot study in the Deep South
Konkle‐Parker, D. J., Erlen, J. A., & Dubbert, P. M. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.04.010 · Cited by 31
“Other possible approaches for assessing ART adherence recently reported in the literature are a random telephone pill count [22] or a rating scale of the last month’s adherence [23].”
MethodPala, A. N., Kempf, M.-C., Konkle‐Parker, D. J., Wilson, T. E., Tien, P. C., Wingood, G. M., Neilands, T. B., Johnson, M. O., Weiser, S. D., Logie, C. H., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003342 · Cited by 26
Tucker, J. A., Simpson, C. A., Huang, J., Roth, D. L., & Stewart, K. E. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0322 · Cited by 24
“Nevertheless, verbal report measures correlate well with laboratory markers of adherence and are less time- and resource-intensive than many other data collection methods.(4,5) Debate continues, however, about necessary time frames for obtaining accurate adherence reports that can provide clinically meaningful data, (…”
BackgroundScheuermann, T. S., Berg, C. J., Cox, L. S., Nazir, N., Benowitz, N. L., Yu, L., Yturralde, O., Jacob, P., Choi, W. S., Ahluwalia, J. S., et al. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr333 · Cited by 24
Wilson, K. S., Wanje, G., Yuhas, K., Simoni, J. M., Masese, L. N., Stoep, A. V., Jaoko, W. G., Hughes, J. P., Richardson, B. A., & McClelland, R. S. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1420-z · Cited by 27
“We also evaluated adherence in the past 30 days using a validated single-item self-rating scale [37].”
MethodResultAdejumo, O., Oladeji, B. D., Akpa, O. M., Malee, K., Baiyewu, O., Ogunniyi, A. O., Evans, S. R., Berzins, B., & Taiwo, B. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462415600582 · Cited by 29
Kanyangarara, M., Katz, J., Munos, M. K., Khatry, S. K., Mullany, L. C., & Walker, N. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2247-1 · Cited by 25
Parperis, K. M., Psarelis, S., Chatzittofis, A., Michaelides, M., Nikiforou, D., Antoniade, E., & Bhattarai, B. (2021) · Rheumatology · doi:10.1093/rheumatology/keab123 · Cited by 26
Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study
Doró, P., Benkő, R., Czakó, A., Matúz, M., Thurzó, F., & Soós, G. (2011) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-011-9529-7 · Cited by 23
“... possible reason for this finding is that during a shorter period of time, because of the smaller number of potential medication taking events, a mistake in the recall would result in a relatively higher degree of error than for longer recall periods (for example: 1 recall mistake in a once daily regimen would caus…”
BackgroundInfluentialHajj, A., Obeïd, S., Sahyoun, S., Haddad, C., Azar, J., Khabbaz, L. R., & Hallit, S. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194753 · Cited by 25
Asking about adherence – from flipping the coin to strong evidence
Glass, T. R., & Cavassini, M. L. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14016 · Cited by 28
Kekwaletswe, C. T., Jordaan, E., Nkosi, S., & Morojele, N. K. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1595-3 · Cited by 27
Reeder, C., Neilands, T. B., Palar, K., & Saberi, P. (2019) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2019.02.023 · Cited by 23
“TheARTadherence rating question read as such: “Thinking back over the past 30 days, rate your ability to take all your medications as prescribed: excellent, very good, good, fair, poor, or very poor” [19].”
BackgroundMedication Adherence in 13- to 24-Year-Old Youth Living With HIV
Chenneville, T., Machacek, M. G., Walsh, A. S. J., Emmanuel, P. J., & Rodriguez, C. A. (2016) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2016.11.002 · Cited by 23
Williams, E. C., Bradley, K. A., Balderson, B. H. K., McClure, J. B., Grothaus, L. C., McCoy, K., Rittmueller, S. E., & Catz, S. L. (2014) · Substance Abuse · doi:10.1080/08897077.2014.890997 · Cited by 23
“Sociodemographic characteristics Female 125 (28) Age 50–54 263 (59) 55-59 126 (28) 60 58 (13) Race Black 244 (55) White 166 (37) Other* 37 (8) Hispanic ethnicity 29 (6) Educational level high school 222 (50) Sexual orientation Heterosexual 248 (56) LGBT 196 (44) Married/partnered 107 (24) Employment status Full time 3…”
BackgroundFahrni, M. L., Saman, K. M., Alkhoshaiban, A. S., Naimat, F., Ramzan, F., & Isa, K. A. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057868 · Cited by 29
Berghoff, C. R., Gratz, K. L., Portz, K. J., Pinkston, M. M., Naifeh, J. A., Evans, S. D., Konkle‐Parker, D. J., & Tull, M. T. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1745-2 · Cited by 23
Farhat, R., Assaf, J., Jabbour, K., Licha, H., Hajj, A., Hallit, S. R., & Khabbaz, L. R. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.09.005 · Cited by 31
Correlates of Antiretroviral and Antidepressant Adherence Among Depressed HIV-Infected Patients
Bottonari, K. A., Tripathi, S. P., Fortney, J. C., Curran, G. M., Rimland, D., Rodriguez‐Barradas, M. C., Gifford, A. L., & Pyne, J. M. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0218 · Cited by 21
“Even so, future trials may want to build on our results using more objective methods of measurement such as MEMS caps, pill count, or pharmacy record review and utilize a window of measurement that is longer than 4 days.(46) Additionally, we believe that limitations in the variable ‘‘patient’s knowledge of regimen’’ m…”
Patton, D., Francis, J., Clark, E. V., Smith, F. J., Cadogan, C. A., Ryan, C. A., & Hughes, C. M. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0506-6 · Cited by 20
Lauffenburger, J. C., Fontanet, C. P., Isaac, T., Gopalakrishnan, C., Sequist, T. D., Gagne, J. J., Jackevicius, C. A., Fischer, M. A., Solomon, D. H., & Choudhry, N. K. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.06.012 · Cited by 23
“Other metrics ask about use during shorter timewindows, yet prior work has suggested that a 1-month recall window may best approximate adherence—ie, the recall window in this 3item metric.(36,37) These results have several important insights relevant to clinical care.”
BackgroundZeng, X. L., Heneghan, M. B., & Badawy, S. M. (2023) · Current Oncology · doi:10.3390/curroncol30010056 · Cited by 28
“Studies correlating MEMS cap data with self-reporting in adults with hypertension [58] and HIV [59] demonstrated more precise reporting of behavioral adherence with less overreporting in a 30-day period, compared to shorter intervals.”
MethodOwnby, R. L., Waldrop‐Valverde, D., Davenport, R., Simonson, M. R., Caballero, J., Purcell, D. J., Purcell, D. J., Ayala, V., González, J., Patel, N., et al. (2024) · Journal of Ageing and Longevity · doi:10.3390/jal4020005 · Cited by 20
“The Gonzalez-Lu questions were included as a measure of adherence because they have been validated against electronically recorded medication adherence and for their simplicity [96,97].”
Cuevas, C. D. L., Peñate, W., de Cecilia, J. M. G., & de León, J. (2017) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2017.11.003 · Cited by 24
Ming, K., Shrestha, I., Vazquez, A., Wendelborn, J., Jimenez, V., Lisha, N. E., Neilands, T. B., Scott, H. M., Liu, A., Steward, W. T., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040734 · Cited by 22
“Medication adherence is evaluated based on the questions: Rate your ability to take your medication as directed by your HCP in the last 30 days (response options range from ‘excellent’ to ‘very poor’) 26 and How many pills would you estimate you have taken in the last 30 days?”
Psaros, C., Stanton, A. M., Raggio, G. A., Mosery, N., Goodman, G. R., Briggs, E. S., Williams, M., Bangsberg, D. R., Smit, J. A., & Safren, S. A. (2022) · International Journal of Behavioral Medicine · doi:10.1007/s12529-022-10071-z · Cited by 25
“Adherence to ART during the previous month was measured through a composite score developed by Lu and colleagues [50].”
MethodSelf-citationValidity assessment of the PROMIS fatigue domain among people living with HIV
Gibbons, L. E., Fredericksen, R. J., Batey, D. S., Dant, L., Edwards, T. C., Mayer, K. H., Mathews, W. C., Morales, L. S., Mugavero, M. J., Yang, F. M., et al. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0146-y · Cited by 20
Developing the Diagnostic Adherence to Medication Scale (the DAMS) for use in clinical practice
Garfield, S., Eliasson, L., Clifford, S., Willson, A., & Barber, N. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-350 · Cited by 19
“Lu: The Lu questionnaire [13] produces three separate scores for frequency, percentage and rating.”
BackgroundMethodSatyanarayana, S., Rogers, B. G., Bainter, S. A., Christopoulos, K., Fredericksen, R. J., Mathews, W. C., Moore, R. D., Mugavero, M. J., Napravnik, S., Carrico, A. W., et al. (2021) · AIDS Patient Care and STDs · doi:10.1089/apc.2021.0004 · Cited by 22
Self-citationProvider Guidance for Linking Patients to Antiretroviral Therapy Adherence Interventions
Amico, K. R., Zuniga, J. M., Wilson, I. B., Gross, R., & Young, B. (2013) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/1545109712474844 · Cited by 19
“For items asking individuals to estimate execution more generally, with response options that are generally ordinal, capturing the past 30 days appears optimal.(5,7) In the GRIP guide, the item uses ‘‘past 30 days’’ specifically, rather than past month or past 4 weeks.”
BackgroundSelf-citationYoong, J., Traeger, L. N., Gallagher, E. R., Pirl, W. F., Greer, J. A., & Temel, J. S. (2013) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0400 · Cited by 21
“40,43 Covariates.”
InfluentialTang, A., Sheehan, H. B., Jordan, M. R., Duong, D. V., Terrin, N. C., Dong, K. R., Lien, T. T. M., Trung, N. V., WANKE, C. A., & Hiền, N. Đ. (2011) · AIDS Research and Treatment · doi:10.1155/2011/890308 · Cited by 19
“Adherence to ART was assessed by the patient’s subjective rating of how well he was able to take all of his prescribed HIV medications in the past 30 days using a 5-point Likert scale with responses of excellent, very good, good, fair, or poor [11].”
MethodMeyers‐Pantele, S. A., Sullivan, P. S., Mansergh, G., Hirshfield, S., Stephenson, R. B., & Horvath, K. J. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03500-9 · Cited by 20
Sheinfil, A. Z., Foley, J. D., Moskal, D., Dalton, M. R., Firkey, M. K., Ramos, J. M., Maisto, S. A., & Woolf‐King, S. E. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03657-x · Cited by 19
Zongo, A., Guénette, L., Moisan, J., & Grégoire, J. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.06.008 · Cited by 18
The measurement of risk perceptions: the case of smoking
Baghal, T. A. (2011) · Journal of Risk Research · doi:10.1080/13669877.2010.541559 · Cited by 19
“Studies have also found that subjective probabilities measured by vague quantifiers predicted respondents’ behaviors and preferences at least as well, and frequently better than numeric scales (Diefenbach, Weinstein, and O’Reilly 1993; Lu et al. 2008; Weinstein and Diefenbach 1997; Windschitl and Wells 1996).”
BackgroundWhat Time is it? Adherence to Antiretroviral Therapy in Ethiopia
Tiruneh, Y. M., & Wilson, I. B. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1322-0 · Cited by 19
“Patients and clinicians conceptualize missed or delayed doses variably [24] and very few studies have accounted for dose timing when measuring adherence [28, 30].”
InfluentialSelf-citationMcCluskey, S. M., Boum, Y., Musinguzi, N., Haberer, J. E., Martin, J. N., Hunt, P. W., Marconi, V. C., Bangsberg, D. R., & Siedner, M. J. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001479 · Cited by 18
Fredericksen, R. J., Harding, B. N., Ruderman, S. A., McReynolds, J., Barnes, G., Lober, W. B., Fitzsimmons, E., Nance, R. M., Whitney, B. M., Delaney, J. A., et al. (2020) · AIDS Care · doi:10.1080/09540121.2020.1845288 · Cited by 20
Sevelius, J. M., Dilworth, S. E., Reback, C. J., Chakravarty, D., Castro, D. A., Johnson, M. O., McCree, B., Jackson, A., Mata, R. P., & Neilands, T. B. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003014 · Cited by 23
Evans, S. D., Mellins, C. A., Leu, C., Warne, P. A., Elkington, K. S., Dolezal, C. L., Santamaria, E. K., WIZNIA, A. A., Bamji, M., Jurgrau, A., et al. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0058 · Cited by 18
“6) HIV + 57 (29) 55 (36) 35 (26) 13 (30) African American 101 (52) 88 (56) 74 (51) 24 (45) Latino 72 (37) 50 (32) 55 (38) 23 (43) Biological parent 67 (35) 62 (40) 44 (31) 11 (24) Employed 55 (28) 35 (23) 53 (39) 14 (32) Education 11.”
Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy
Nakhutina, L., Kunnakkat, S., Coleman, M., Lushbough, C., Arnedo, V., Soni, N., & Grant, A. C. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.05.001 · Cited by 18
“This measure is drawn from validation research where it demonstrated close concordance with electronically monitored adherence in HIV/AIDS [16].”
MethodChkhartishvili, N., Rukhadze, N., Svanidze, M., Sharvadze, L., DeHovitz, J. A., Tsertsvadze, T., McNutt, L., & del Río, C. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.18885 · Cited by 20
“For the purposes of analysis, each response category was assigned a corresponding adherence score: very poor 0%, poor 20%, fair 40%, good 60%, very good 80% and excellent 100% [16].”
MethodYiğit, İ., Bayramoglu, Y., Weiser, S. D., Johnson, M. O., Mugavero, M. J., Turan, J. M., & Turan, B. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002593 · Cited by 20
Markowitz, S. M., Carper, M. M., Gonzalez, J. S., Delahanty, L. M., & Safren, S. A. (2012) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.11m01220 · Cited by 17
Self-citationSaberi, P., Ming, K., Legnitto, D., Neilands, T. B., Gandhi, M., & Johnson, M. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210791 · Cited by 17
The HNRP Group, Blackstone, K., Woods, S. P., Weber, E., Grant, I., & Moore, D. J. (2012) · AIDS and Behavior · doi:10.1007/s10461-012-0308-9 · Cited by 19
“Previous studies support the use of MEMS as a more accurate estimate of adherence than self-report or pill counts (both of which tend to overestimate adherence [29, 30].”
ResultSoto, T., Komaie, G., Neilands, T. B., & Johnson, M. O. (2013) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2012.11.008 · Cited by 18
“For participants who were on ART, the assessment included a 30-day adherence rating scale, recommended by Lu et al. (2008), in which participants were asked, ‘‘Thinking back over the past 30 days, rate your ability to take all your medications as prescribed.’’”
MethodPatton, D., Pearce, C. J., Cartwright, M., Smith, F. J., Cadogan, C. A., Ryan, C. A., Clark, E. V., Francis, J., & Hughes, C. M. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00762-3 · Cited by 17
Baghal, T. A. (2014) · Survey research methods · doi:10.18148/srm/2014.v8i3.5813 · Cited by 22
“The closest to examining response differences is Lu et al. (2008); however, these researchers use an uncommon variation of frequency estimation (percentage scales) rather than the frequently used open-ended format.”
InfluentialJordan, M. R., Obeng-Aduasare, Y. F., Sheehan, H. B., Sy, H., Terrin, N. C., Duong, D., Trung, N. V., Wanke, C. A., Kinh, N., & Tang, A. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413516301 · Cited by 16
Impact and correlates of sub-optimal social support among patients in HIV care
Fredericksen, R. J., Gibbons, L. E., Fitzsimmons, E., Nance, R. M., Schafer, K. R., Batey, D. S., Loo, S. S., Dougherty, S., Mathews, W. C., Christopoulos, K., et al. (2021) · AIDS Care · doi:10.1080/09540121.2020.1853660 · Cited by 23
“…Scale (Likert scale, very poor to excellent) and a 30-day visual analog scale (0–100% of medication taken in past month) (Chesney et al., 2000; Lu et al., 2008; Simoni et al., 2006); substance use (AUDIT/AUDIT-C for alcohol use, ASSIST for other substances) (Bradley et al., 2003; Bush et…”
MethodRobbins, G. K., Testa, M. A., Su, M., Safren, S. A., Morse, G. D., Lammert, S. M., Shafer, R. W., Reynolds, N. R., & Chesney, M. A. (2013) · HIV Clinical Trials · doi:10.1310/hct1405-235 · Cited by 17
“28,29 Finally, phone interventions were not monitored to ensure compliance with the script, and as discussed above, there was the potential for control subjects to receive the intervention telephone calls.”
Self-citationSelf-reported compliance with osteoporosis medication—Qualitative aspects and correlates
Vytrisalova, M., Blazkova, S., Palička, V., Vlček, J., Cejkova, M., Hala, T., Pavelká, K., & Koblihová, H. Š. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.07.009 · Cited by 16
Torres‐Madriz, G., Lerner, D., Ruthazer, R., Rogers, W. H., & Wilson, I. B. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9667-2 · Cited by 16
“Subjects We used data from a randomized, crossover trial testing a physician-focused intervention to improve adherence to HIV ART [14, 15].”
Self-citationHaddad, C., Hallit, S. R., Salhab, M., Hajj, A., Sarkis, A., Ayoub, E. N., Jabbour, K., & Khabbaz, L. R. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418769635 · Cited by 20
Mensch, B., Brown, E. R., Liu, K., Marrazzo, J. M., Chirenje, Z. M., Gomez, K., Piper, J. M., Patterson, K., & van der Straten, A. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1312-2 · Cited by 16
“’’ These statements were then followed by two questions about frequency of missed or skipped days, ‘‘How often during the study did you miss or skip days?’’ and when this first occurred, ‘‘When during the study did you start skipping doses?’’ The final set of adherence assessments began with a question asking particip…”
BackgroundZhou, S., Toska, E., Langwenya, N., Edun, O., Cluver, L. D., & Knight, L. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04068-2 · Cited by 15
“Previous research demonstrates that short-term self-reported measures may overestimate adherence due to recall and social desirability bias [18, 45, 46].”
BackgroundLiao, R., Tang, Z., Zhang, N., Hu, L., Chang, Z., Ren, J., Bai, X., Shi, J. L., Fan, S., Pei, R., et al. (2024) · Infectious Diseases of Poverty · doi:10.1186/s40249-024-01221-4 · Cited by 19
Taylor, S. W., McKetchnie, S. M., Batchelder, A., Justice, A. C., Safren, S. A., & O’Cleirigh, C. M. (2022) · AIDS Care · doi:10.1080/09540121.2022.2076801 · Cited by 16
Self-citationEvaluation of 3 Approaches for Assessing Adherence to Vaginal Gel Application in Clinical Trials
van der Straten, A., Cheng, H., Mensch, B., Friedland, B., Katzen, L. L., Littlefield, S., Buckley, N. J., Espinoza, L., Keller, M. J., Herold, B. C., et al. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000053 · Cited by 15
“The 6 categories were assigned scores of 0% to 100% adherence, following Lu et al.(18) The association between all 6 adherence measures was determined via a Spearman rank correlation coefficient.”
MethodResultTsuyuki, K., SHOPTAW, S. J., Ransome, Y., Chau, G., Rodríguez-Díaz, C. E., Friedman, R. K., Srithanaviboonchai, K., Li, S., Mimiaga, M. J., Mayer, K. H., et al. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02415-w · Cited by 15
Self-citationComulada, W. S., Step, M. M., Fletcher, J. B., Tanner, A. E., Dowshen, N., Arayasirikul, S., Baker, K. K., Zuniga, J., Swendeman, D. T., Medich, M., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/18309 · Cited by 18
“Antiretroviral Therapy Adherence Antiretroviral therapy (ART) adherence was assessed using the self-rating scale item [20,21].”
Method
Metadata
- Authors
- Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., & Wilson, I. B.
- Affiliations
- Tufts Medical Center (US)
- Harvard University (US)
- Boston University (US)
- Corresponding author
- Wilson, Ira B.
- Venue
- AIDS and Behavior
- Published
- 2007-06-19
- Volume
- 12
- Issue
- 1
- Pages
- 86-94
- ISSN
- 1090-7165 (ISSN-L)
- 1573-3254
- OpenAlex
- W2054763716
- Cited by
- 361
- References
- 44
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 21 · 2022: 17 · 2021: 30 · 2020: 21 · 2019: 18 · 2018: 27 · 2017: 19 · 2016: 29 · 2015: 19 · 2014: 22 · 2013: 30 · 2012: 18
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- AIDS and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Center for AIDS Research, University of Washington
- Research England
- National Institute on Drug Abuse (R01DA015679)
- National Institute of Allergy and Infectious Diseases (P30-AI 42853, P30AI042853)
- National Center for Research Resources (M01 RR-00054, M01RR000054, K24RR020300)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Keywords
- HIV treatment adherence, antiretroviral therapy, self-report measures, recall period, overreporting, medication event monitoring system, measurement accuracy, rating scales
- MeSH terms
- Adult, Electronics, Female, Humans, Male, Patient Compliance, Surveys and Questionnaires, Mental Recall, Self Administration, Self Disclosure, Time Factors, HIV Infections, Treatment Outcome, Drug Monitoring, Cross-Over Studies, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.